Top

Published in:

01-06-2010

Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families

Authors: J. M. Chiang, H. W. Chen, R. P. Tang, J. S. Chen, C. R. Changchien, P. S. Hsieh, J. Y. Wang

Published in: Familial Cancer | Issue 2/2010

Abstract

Familial adenomatous polyposis (FAP) is an autosomal-dominant disease caused by germline mutations in the adenomatous polyposis coli (APC) gene. The affected individuals develop colorectal polyposis and show various extra-colonic manifestations. In this study, we aimed to investigate the genetic and clinical characteristics of FAP in Taiwanese families and analyze the genotype–phenotype correlations. Blood samples were obtained from 66 FAP patients registered in the hereditary colorectal cancer database. Then, germline mutations in the APC genes of these 66 polyposis patients from 47 unrelated FAP families were analyzed. The germline-mutation-negative cases were analyzed by performing multiplex ligation-dependent probe amplification (MLPA) and single-strand conformation polymorphism (SSCP) analysis of the MUTYH gene. Among the analyzed families, 79% (37/47) of the families showed 28 APC mutations, including 19 frameshift mutations, 4 nonsense mutations, 3 genomic deletion mutations, 1 missense mutation, and 1 splice-site mutation. In addition, we identified 15 novel mutations in 32% (15/47) of the families. The cases in which APC mutations were not identified showed significantly lower incidence of profuse polyposis (P = 0.034) and gastroduodenal polyps (P = 0.027). Furthermore, FAP families in which some affected individuals had less than 100 polyps showed significant association with low incidence of APC germline mutations (P = 0.002). We have added the APC germline-mutation data for Taiwanese FAP patients and indicated the presence of an FAP subgroup comprising affected individuals with nonadenomatous polyps or less than 100 adenomatous polyps; this form of FAP is less frequently caused by germline mutations of the APC gene.

Kinzler KW, Nilbert MC, Vogelstein B et al (1991) Identification of FAP locus genes from chromosomes 5q21. Science 253:661–664CrossRefPubMed

Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis gene. Cell 66:589–600CrossRefPubMed

Su L-K, Kohlmann W, Ward PA et al (2002) Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15. Hum Genet 111:88–95CrossRefPubMed

Michils G, Tejpar S, Thoelen R et al (2005) Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutation 25:125–134CrossRef

Flintoff KJ, Sheridan E, Turner G, Chu CE, Taylor GR (2001) Submicroscopic deletions of the APC gene: a frequent cause of familial adenomatous olyposis that may be overlooked by conventional mutation scanning. J Med Genet 38:129–132CrossRefPubMed

Sieber OM, Lamlum H, Crabtree MD et al (2002) Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple colorectal adenomas”. Proc Natl Acad Sci USA 99:2954–2958CrossRefPubMed

Bunyan DJ, Eccles DM, Silibourme J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159CrossRefPubMed

Sellner LN, Taylor GR (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mut 23:413–419CrossRefPubMed

Friedl W, Caspari R, Sengteller M et al (2001) Can APC mutation analysis contribute to therapeiutic decisions in familial adenomatous polyposis? experience from 680 FAP families. Gut 48:515–521CrossRefPubMed

10.

Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011–3020PubMed

11.

Moisio A-L, Jarvinen H, Peltomaki P (2002) Genetic and clinical characterization of familial adenomatous polyposis: a population based study. Gut 50:845–850CrossRefPubMed

12.

Mandl M, Paffenholz R, Friedl W et al (1994) Frequency of common and novel inactivationg APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet 3:181–184CrossRefPubMed

13.

Crabtree MD, Tomlinson IPM, Hodgson SV, Neale K, Phillips RKS (2002) Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut 51:420–423CrossRefPubMed

14.

Bisgaard ML, Ripa R, Knudsen AL, Bulow S (2004) Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut 53:266–270CrossRefPubMed

15.

Heinimann K, Mullhaupt B, Weber W et al (1998) Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 43:675–679PubMedCrossRef

16.

Kairupan CF, Meldrum CJ, Crooks R, Milward EA, Spegelman AD, Burgess B (2005) Mutation analysis of the MYH gene in an Australian series of colorectal Polyposis patients with or without germline APC mutations. Int J Cancer 116:73–77CrossRefPubMed

17.

Prosser J, Condie A, Wright M et al (1994) APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer 70:841–846PubMed

18.

Miyoshi Y, Ando H, Nagase H et al (1992) Germ-line mutations of APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456CrossRefPubMed

19.

Stella A, Resta N, Gentile M, Susca F, Mareni C, Montera MP, Guanti G (1993) Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP). Am J Hum Genet 53:1031–1037PubMed

20.

Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, Lanspa S, Smyrk T, Cavalier J, Howard L, Burt R, White R, Leppert M (1992) Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 51:92–100PubMed

21.

Cao X, Eu KW, Seow-Choen F, Zao Y, Cheah PY (2000) APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients. Eur J Hum Genet 8:42–48CrossRefPubMed

22.

Kim DW, Kim IJ, Kang HC et al (2005) Mutation spectrum of the APC gene in 83 Korean FAP families. Hum Mutat 26:281CrossRefPubMed

23.

Scott RJ, Meldrum C, Crooks R et al (2001) Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut 48:508–514CrossRefPubMed

24.

Giardiello FM, Krush AJ, Petersen GM et al (1994) Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 106:1542–1547PubMed

25.

Ruiz-Ponte C, Vega A, Carracedo A, Barros F (2001) Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Hum Mutat 18:355CrossRefPubMed

26.

Aretz S, Uhlhaas S, Caspari R et al (2004) Frequency and parenteral origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 12:52–58CrossRefPubMed

27.

Ripa R, Bisgaard ML, Bulow S, Nielsen FC (2002) De novo mutations in familial adenomatous polyposis (FAP). Eur J Hum Genet 10:887–888CrossRef

Title: Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families
Authors: J. M. Chiang
H. W. Chen
R. P. Tang
J. S. Chen
C. R. Changchien
P. S. Hsieh
J. Y. Wang
Publication date: 01-06-2010
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 2/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-009-9292-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient

Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong

Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis

Heredity, diet and lifestyle as determining risk factors for the esophageal cancer on Nanao Island in Southern China

Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection

No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome

Keynote webinar | Spotlight on antibody–drug conjugates in cancer